Application Note Pharma & Biopharma Mobile Phase Optimization in SEC Method Development Author Richard Hurteau Agilent Technologies, Inc., Wilmington, DE, USA Abstract Aggregation of monoclonal antibody (mAb) products has an adverse effect on their efficacy as therapeutic agents. Size exclusion…
Klíčová slova
mau, min, igg, phosphate, insulin, kda, aggregation, buffer, adc, cytochrome, columns, proteins, nriu, peak, therapeutic